Evidence map›Paper›PMID 35782954›Full record

ArticleFrontiers in nutrition2022

Multi-Omic Analyses Reveal Bifidogenic Effect and Metabolomic Shifts in Healthy Human Cohort Supplemented With a Prebiotic Dietary Fiber Blend.

Jea Woo Kang, Xinyu Tang, Charles J Walton, Mark J Brown, Rachel A Brewer, Rolando L Maddela, Jack Jingyuan Zheng, Joanne K Agus, Angela M Zivkovic

Registry-linked trialOpen access · goldAbstract readCase Reports
In one paragraph

Article in Frontiers in nutrition, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03785860 (The Effects of Dietary Fiber on the Gut Microbiome and HDL Particles of Human Subjects), which is not on this map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03785860 nacompletednot on this map

The Effects of Dietary Fiber on the Gut Microbiome and HDL Particles of Human Subjects

TypeinterventionalSponsorUniversity of California, DavisRan2019 to 2019Enrolled20ConditionsGut MicrobiotaArmsDietary Fiber, Placebo
3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 17 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Jea Woo KangDepartment of Nutrition, University of California, Davis, Davis, CA, United States.
Xinyu TangDepartment of Nutrition, University of California, Davis, Davis, CA, United States.
Charles J WaltonUSANA Health Sciences, Inc., Salt Lake City, UT, United States.
Mark J BrownUSANA Health Sciences, Inc., Salt Lake City, UT, United States.
Rachel A BrewerUSANA Health Sciences, Inc., Salt Lake City, UT, United States.
Rolando L MaddelaUSANA Health Sciences, Inc., Salt Lake City, UT, United States.
Jack Jingyuan ZhengDepartment of Nutrition, University of California, Davis, Davis, CA, United States.
Joanne K AgusDepartment of Nutrition, University of California, Davis, Davis, CA, United States.
Angela M ZivkovicDepartment of Nutrition, University of California, Davis, Davis, CA, United States.
University of California, Davis · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dietary fiber, a nutrient derived mainly from whole grains, vegetables, fruits, and legumes, is known to confer a number of health benefits, yet most Americans consume less than half of the daily recommended amount. Convenience and affordability are key factors determining the ability of individuals to incorporate fiber-rich foods into their diet, and many Americans struggle to access, afford, and prepare foods rich in fiber. The objective of this clinical study was to test the changes in microbial community composition, human metabolomics, and general health markers of a convenient, easy to use prebiotic supplement in generally healthy young participants consuming a diet low in fiber. Twenty healthy adults participated in this randomized, placebo-controlled, double-blind, crossover study which was registered at clinicaltrials.gov as NCT03785860. During the study participants consumed 12 g of a prebiotic fiber supplement and 12 g of placebo daily as a powder mixed with water as part of their habitual diet in randomized order for 4 weeks, with a 4-week washout between treatment arms. Fecal microbial DNA was extracted and sequenced by shallow shotgun sequencing on an Illumina NovaSeq. Plasma metabolites were detected using liquid chromatography-mass spectrometry with untargeted analysis. The phylum Actinobacteria, genus Clinical Trial Registration: www.clinicaltrials.gov/, identifier: NCT03785860.

Indexed as

bifidobacteriacholinesgut microbiomeindolepropionateprebiotic

Identifiers

PMID35782954
PMCPMC9248813
OpenAlexW4283034819

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.